MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Preventing blindness

Back to ophthalmology news Blogs list Cancer blog  


Subscribe To Ophthalmology News RSS Feed  RSS content feed What is RSS feed?

Preventing blindness




Automated Medical Diagnostics, a startup company based in Memphis, envisions its product helping to preserve the sight of millions of people who are at risk of vision loss from diabetic retinopathy.

Using Telemedical Retinal Image Analysis and Diagnosis, a technology recently licensed by AMDx from the Department of Energy's Oak Ridge National Laboratory and the University of Tennessee Health Science Center, patients can quickly be screened for the disease in their primary care doctor's office and other remote sites, permitting early detection and referral for diabetic retinopathy and other retinal diseases.



Preventing blindness
Oak Ridge National Laboratory researchers Ken Tobin (left) and Tom Karnowski see TRIAD as something that could be a life-changer for people at risk of diabetic retinopathy and other potentially blinding diseases. (Photo by Ron Walli/ORNL)

"If diabetic retinopathy is detected early, therapys can preserve vision and significantly reduce the occurence rate of debilitating blindness," said Edward Chaum, an ophthalmologist and Plough Foundation professor of retinal diseases at the UT Health Science Center Hamilton Eye Institute in Memphis. Chaum and ORNL's Ken Tobin, partners in AMDx, led the team that developed a method for teaching computers to aid in the diagnosis of diabetic retinopathy and other blinding eye diseases.

The Web-based technology uses a digital camera that takes pictures of the retina at a primary care physician's office or other remote clinical site. The patient's medical data and retinal images are sent to a server and processed through the patented system that quickly sorts through large databases and finds visually similar images representing equivalent states of diabetic eye disease. This allows diagnoses to be made in seconds so patients will know before they leave the office if they have no eye disease or if they need to follow up with a retinal specialist. Conventional techniques require a patient to wait several days to receive results.

"With the TRIAD network, all of the computed diagnoses are sent to an ophthalmologist for review and sign-off of the computer-generated report, much like what is done for an EKG," Tobin said. "Over time, our hope is that the number of reports requiring doctor review will be reduced as the performance of the TRIAD network is proven through clinical testing."

For more than a decade, manufacturers of semiconductors have used this technology to rapidly scan hundreds of thousands of tiny semiconductors for defects and to learn quickly about problems in the manufacturing process. Since 2005, Chaum, Tobin and his colleagues have been supported by grants from the National Institutes of Health and other federal agencies to test and demonstrate that retinal pathology can be identified and quantified by adapting the content-based image retrieval technology.

"What separates this from other methods is that we have automated the process of diagnosing retinal disease by capturing the expert knowledge of an ophthalmologist in a digital patient archive," Tobin said.

This allows far more people to undergo screening, particularly the indigent and those in areas that are medically underserved.

"Today, less than half of Americans known to be diabetic receive the recommended yearly examination because they either cannot afford eye exams, lack access to eye care providers or are unable to comply with physicians' recommendations," Chaum said. "In the next 15 years we will need to be able to screen more than 1 million patients every day worldwide in order to detect and manage vision loss and blindness due to diabetes.

"By using automated computer-assisted diagnostic methods like TRIAD and the connectivity of the Web throughout the world, this is an achievable goal."

Tobin and Chaum see AMDx and TRIAD as a game changer, providing diabetic patients with easy access to screening cameras in primary care medical practices and a variety of other settings.


Posted by: Mike    Source




Did you know?
Automated Medical Diagnostics, a startup company based in Memphis, envisions its product helping to preserve the sight of millions of people who are at risk of vision loss from diabetic retinopathy. Using Telemedical Retinal Image Analysis and Diagnosis, a technology recently licensed by AMDx from the Department of Energy's Oak Ridge National Laboratory and the University of Tennessee Health Science Center, patients can quickly be screened for the disease in their primary care doctor's office and other remote sites, permitting early detection and referral for diabetic retinopathy and other retinal diseases.

Medicineworld.org: Preventing blindness

Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news| Pancreatic cancer news| Prostate cancer news| Endometrial cancer news| General info| What is cancer?| Cancer causes| Is cancer hereditary?| Types of cancer| Cancer statistics| Breast cancer main| Breast cancer symptoms| Colon cancer main| Anal cancer| Bladder cancer main| Lung cancer general| Lung cancer main| Non small cell| Small cell| Ovarian cancer main| Treatment of ovarian cancer| Prostate cancer main| Updates in oncology| Acute myeloid leukemia|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.